Atopic Dermatitis Treated With Dupilumab and JAK Inhibitors in Costa Rica

Clinical trial NCT07448363 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07448363
Sponsor: Caja Costarricense de Seguro Social
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Atopic Dermatitis Atopic Dermatitis (AD)Atopic Dermatitis (Eczema)Atopic Dermatitis Patients Atopic Dermatitis / Eczema Atopic Dermatitis, Unspecified

Start date: 2026-05-01
Primary completion: 2031-05-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.